B E Edwards1, J D Gearhart, E E Wallach. 1. Department of Gynecology and Obstetrics, The Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA.
Abstract
OBJECTIVE: To discuss the current state of the science surrounding human pluripotent stem cells and to show that the derivation of such cells from donated preimplantation human embryos should be eligible for federal funding provided that certain protections are met. DESIGN: A literature search focusing on the scientific aspects of pluripotent stem-cell research and analyses of current and past legislation and federal panel recommendations. CONCLUSION(S): The current federal laws regulating the permission necessary to obtain fetal tissue from elective pregnancy terminations are intended to insulate the decision to terminate a pregnancy from the potential positive influence of fetal tissue transplantation. A similar situation can be created for the derivation of cells from excess preimplantation human embryos produced by IVF programs. If, as in fetal tissue research, assurances can be made that the research will have no influence on the decision to dispose of the embryo, the derivation of pluripotent stem cells from embryo should proceed with federal funding.
OBJECTIVE: To discuss the current state of the science surrounding human pluripotent stem cells and to show that the derivation of such cells from donated preimplantation human embryos should be eligible for federal funding provided that certain protections are met. DESIGN: A literature search focusing on the scientific aspects of pluripotent stem-cell research and analyses of current and past legislation and federal panel recommendations. CONCLUSION(S): The current federal laws regulating the permission necessary to obtain fetal tissue from elective pregnancy terminations are intended to insulate the decision to terminate a pregnancy from the potential positive influence of fetal tissue transplantation. A similar situation can be created for the derivation of cells from excess preimplantation human embryos produced by IVF programs. If, as in fetal tissue research, assurances can be made that the research will have no influence on the decision to dispose of the embryo, the derivation of pluripotent stem cells from embryo should proceed with federal funding.
Entities:
Keywords:
Biomedical and Behavioral Research; Genetics and Reproduction
Authors: P Jeanette Simpson; Ian Miller; Cheil Moon; Andrea L Hanlon; Daniel J Liebl; Gabriele V Ronnett Journal: J Neurosci Date: 2002-07-01 Impact factor: 6.167
Authors: Michael Wille; Antje Schümann; Michael Kreutzer; Michael O Glocker; Andreas Wree; Grit Mutzbauer; Oliver Schmitt Journal: Proteome Sci Date: 2015-02-15 Impact factor: 2.480